بدائل البحث:
significant decrease » significant increase (توسيع البحث), significantly increased (توسيع البحث)
clinical decrease » clinical disease (توسيع البحث), clinical case (توسيع البحث), linear decrease (توسيع البحث)
increase » increased (توسيع البحث)
significant decrease » significant increase (توسيع البحث), significantly increased (توسيع البحث)
clinical decrease » clinical disease (توسيع البحث), clinical case (توسيع البحث), linear decrease (توسيع البحث)
increase » increased (توسيع البحث)
-
861
-
862
-
863
Specifications and outcomes of clinical trial studies included in the meta-analysis.
منشور في 2025الموضوعات: -
864
-
865
-
866
-
867
Annual incidence of insomnia disorder (ICD-CODE: G47) Bar: rate of insomnia disorder relative to all patients; Line: average number of outpatient visits for patients with insomnia...
منشور في 2025الموضوعات: "…treatment initiation decreased…"
-
868
Distribution of non-pharmacological treatment related to insomnia disorder (2002–2019).
منشور في 2025الموضوعات: "…treatment initiation decreased…"
-
869
Detailed treatment status of patients who did not receive non-pharmacological treatment at first diagnosis but received it later.
منشور في 2025الموضوعات: "…treatment initiation decreased…"
-
870
Mean interval from initial diagnosis to initiation of non-pharmacological treatment by year.
منشور في 2025الموضوعات: "…treatment initiation decreased…"
-
871
General information of patient who diagnosis insomnia disorder (N = 518,119).
منشور في 2025الموضوعات: "…treatment initiation decreased…"
-
872
Detailed treatment status of people who received non- pharmacological treatment at first diagnosis.
منشور في 2025الموضوعات: "…treatment initiation decreased…"
-
873
Treatment at first diagnosis of insomnia disorder (%).
منشور في 2025الموضوعات: "…treatment initiation decreased…"
-
874
-
875
Charts revealing A) the significant decrease (<i>p</i> < 0.05) in the membrane integrity and B) the significant increase (<i>p</i> < 0.05) in the membrane permeability after treatment with harmalacidine hydrochloride in a representative <i>S. aureus</i> isolate (n = 3 as technical repeats of the same isolate).
منشور في 2025"…<p>Charts revealing A) the significant decrease (<i>p</i> < 0.05) in the membrane integrity and B) the significant increase (<i>p</i> < 0.05) in the membrane permeability after treatment with harmalacidine hydrochloride in a representative <i>S. aureus</i> isolate (n = 3 as technical repeats of the same isolate).…"
-
876
-
877
Cyclosporin A significantly reduces the survival rate and completely inhibits the formation of multicellular aggregates in tolerant strains under caspofungin stress.
منشور في 2025"…<p>(A) Cyclosporin A decreases the survival rate of tolerant strains under caspofungin. …"
-
878
-
879
-
880